TherapeuticsMD, Inc. Quarterly Debt-to-equity in % from Q1 2012 to Q4 2023

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
TherapeuticsMD, Inc. quarterly Debt-to-equity history and growth rate from Q1 2012 to Q4 2023.
  • TherapeuticsMD, Inc. Debt-to-equity for the quarter ending December 31, 2023 was 71.8 %.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q4 2023 71.8 +452 Dec 31, 2023
Q3 2023 101 +390 Sep 30, 2023
Q2 2023 574 +881 Jun 30, 2023
Q1 2023 -6.1K -5.79K -1853% Mar 31, 2023
Q4 2022 -380 +115 +23.3% Dec 31, 2022
Q3 2022 -289 +162 +35.9% Sep 30, 2022
Q2 2022 -307 +63.5 +17.1% Jun 30, 2022
Q1 2022 -312 +21.6 +6.48% Mar 31, 2022
Q4 2021 -496 -176 -55.1% Dec 31, 2021
Q3 2021 -451 +22.2 +4.69% Sep 30, 2021
Q2 2021 -371 +383 +50.8% Jun 30, 2021
Q1 2021 -334 +1.86K +84.8% Mar 31, 2021
Q4 2020 -320 -1.88K -120% Dec 31, 2020
Q3 2020 -473 -986 -192% Sep 30, 2020
Q2 2020 -754 -946 -493% Jun 30, 2020
Q1 2020 -2.2K -2.32K -1980% Mar 31, 2020
Q4 2019 1.56K Dec 31, 2019
Q3 2019 514 Sep 30, 2019
Q2 2019 192 Jun 30, 2019
Q1 2019 117 Mar 31, 2019
Q4 2015 16.5 Dec 31, 2015
Q3 2015 17.4 Sep 30, 2015
Q2 2014 13.7 -19.5 -58.7% Jun 30, 2014
Q1 2014 12.4 -62.4 -83.4% Mar 31, 2014
Q4 2013 11.6 +272 Dec 31, 2013
Q3 2013 16.3 +228 Sep 30, 2013
Q2 2013 33.1 +259 Jun 30, 2013
Q1 2013 74.8 +225 Mar 31, 2013
Q4 2012 -261 Dec 31, 2012
Q3 2012 -212 Sep 30, 2012
Q2 2012 -226 Jun 30, 2012
Q1 2012 -150 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.